Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 05-2018 | 02-2018 | 11-2017 | 08-2017 | 05-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,231 | 4,947 | 1,297 | 946 | 1,776 |
| TOTAL | $3,321 | $6,617 | $4,735 | $4,282 | $6,121 |
| Non-Current Assets | |||||
| PPE Net | 11 | 12 | 14 | 16 | 17 |
| Intangibles | 1,567 | 1,655 | 1,742 | 1,830 | 1,917 |
| TOTAL | $1,578 | $1,667 | $1,756 | $1,845 | $1,935 |
| Total Assets | $4,899 | $8,285 | $6,491 | $6,128 | $8,055 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,842 | 11,655 | 9,717 | 5,670 | 4,281 |
| Accrued Expenses | 891 | 933 | 1,625 | 943 | 804 |
| TOTAL | $16,733 | $12,588 | $16,734 | $11,108 | $6,144 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,324 | 3,289 | 2,548 | 3,377 | 3,015 |
| TOTAL | $1,324 | $3,289 | $2,548 | $3,377 | $3,015 |
| Total Liabilities | $18,057 | $15,877 | $19,281 | $14,485 | $9,159 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 218,693 | 212,083 | 169,862 | 156,100 | 152,763 |
| Common Shares | 217 | 209 | 165 | 153 | 150 |
| Retained earnings | -173,139 | -163,516 | -145,566 | -134,618 | -122,990 |
| TOTAL | $-13,158 | $-7,593 | $-12,791 | $-8,358 | $-1,103 |
| Total Liabilities And Equity | $4,899 | $8,285 | $6,491 | $6,128 | $8,056 |